Table 1.
HER2 positive cancer patient characteristics.
| Median Age at Diagnosis (range) | 49 (22–83) |
|---|---|
| Patient gender | N (%) |
| Female | 51 (96%) |
| Male | 2 (4%) |
| Patient ethnicity | N (%) |
| Arab | 4 (8) |
| Ashkenazi Jew | 22 (42) |
| Sephardic Jew | 17 (32) |
| Other | 10 (19) |
| Primary tumor Site | N (%) |
| Breast | 53 (93) |
| Gastric | 3 (5) |
| Colon | 1 (2) |
| Tumor Stage | N (%) |
| I | 13 (23) |
| II | 23 (40) |
| III | 7 (12) |
| IIIC-IV | 11 (19) |
| Recurrent | 3 (5) |
| Tumor Pathology | N (%) |
| Adenocarcinoma | 4 (7) |
| Atypical medullary carcinoma | 1 (2) |
| Invasive duct carcinoma | 49 (86) |
| Invasive lobular carcinoma | 2 (4) |
| Invasive micropapillary carcinoma | 1 (2) |
| Tumor ER statues | N (%) |
| + | 33 (63) |
| − | 19 (37) |
| N/A | 5 |
| Tumor HER2 identification | |
| FISH | 6 (10) |
| IHC | 47 (90) |
| TP53 carrier | 3 |
| FoundationOne | 1 |